SEC Form 4 · accession 0001609351-16-000057
Spark Therapeutics, Inc. · ONCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elliot Sigal
Director
Period of report
Jun 1, 2016
Accepted (ET)
Jun 3, 2016 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $56.22 | Jun 1, 2016 | A | 6,000 | A | — | May 31, 2026 | Common Stock | 6,000 | 6,000 | D |
Explanation of responses
- F1100% of the shares vest on the one-year anniversary date of the grant